FDA Approves Sutent For Rare Type Of Pancreatic Cancer
Links shared publicly online about this topic.
- 266total visits
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Diet and Nutrition, Drug, FDA, Surgery
Most Recently Shared on May 26, 2011 at 11:05 am By:
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pharma #pharmaceutical
Also Shared By:
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:06 am By:
MNT Drug Approvals Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3Wc7 #regulatory
Sutent for Rare Type of Pancreatic Cancer Approved by FDA
disabled-world.com — “Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body” View full resource at disabled-world.com
Most Recently Shared on May 22, 2011 at 9:21 pm By:
Disabled World Health Advocate and Health News
Sutent for Rare Type of Pancreatic Cancer Approved by FDA http://ff.im/-DWIfW
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
medworm.com — “FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy” View full resource at medworm.com
Most Recently Shared on May 21, 2011 at 9:32 pm By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 8:13 am By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNew... http://bit.ly/lGiA67 #drug
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 7:16 am By:
FDA Approves Sutent for Rare Type of Pancreatic Cancer - http://bit.ly/j6v3Lp
Medical News: FDA Okays Sunitinib for Rare Pancreatic Tumors - in Oncology/Hematology, Other Cancers from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved Pfizer's sunitinib (Sutent) to treat advanced pancreatic neuroendocrine tumors (pNET) that cannot be removed by surgery or that have spread to other parts of the bod” View full resource at medpagetoday.com
Most Recently Shared on May 21, 2011 at 12:07 am By:
Hisham Rana, MD Doctor and Physician
News: U.S. #FDA okays Sutent (sunitinib) for rare pancreatic tumors http://bit.ly/j7xlW3 - #health
Late-breaking news: FDA approves new treatment for rare type of pancreatic cancer - - ModernMedicine
modernmedicine.com — “FDA has approved everolimus (Afinitor, Novartis) tablets to treat patients with progressive neuroendocrine tumors of pancreatic origin that cannot be removed by surgery or that have spread to other parts of the body (metastatic).” View full resource at modernmedicine.com
Most Recently Shared on May 9, 2011 at 4:21 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
FDA approves new treatment for rare type of pancreatic cancer: http://tinyurl.com/3thp4mm
FDA Approves New Treatment for Rare Type of Pancreatic Cancer - QualityPoint Technologies
qualitypointtech.net — “Source: Food and Drug Administration Related MedlinePlus Page: Pancreatic Cancer (Source: MedlinePlus Health News)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.” View full resource at qualitypointtech.net
Most Recently Shared on May 7, 2011 at 6:45 am By:
FDA Approves New Treatment for Rare Type of Pancreatic Cancer: Source: Food and Drug Administration Related Medlin... http://bit.ly/kieZRn
FDA approves Novartis pancreas cancer drug | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG's cancer drug Afinitor has been approved by the U.S. Food and Drug Administration for a rare type of pancreatic cancer that has few treatment options.Data show Afinitor” View full resource at reuters.com
Most Recently Shared on May 7, 2011 at 12:49 am By:
HealthIT Policy Health News and Health IT
FDA approves Novartis pancreas cancer drug: ZURICH (Reuters) - Novartis AG's cancer drug Afinitor has been appro... http://bit.ly/kfK6KX
FDA approves Novartis pancreas cancer drug | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG's cancer drug Afinitor has been approved by the U.S. Food and Drug Administration for a rare type of pancreatic cancer that has few treatment options.Data show Afinitor” View full resource at reuters.com
Most Recently Shared on May 7, 2011 at 12:22 am By:
FDA approves Novartis pancreas cancer drug http://bit.ly/lO7awg
FDA approves Novartis pancreas cancer drug | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG's cancer drug Afinitor has been approved by the U.S. Food and Drug Administration for a rare type of pancreatic cancer that has few treatment options.Data show Afinitor” View full resource at reuters.com
Most Recently Shared on May 6, 2011 at 9:44 pm By:
FDA approves Novartis pancreas cancer drug http://reut.rs/mMkcKx
Pancreatic Cancer Drug Afinitor Approved By FDA | ThirdAge
thirdage.com — “Pancreatic cancer drug Afinitor by Novartis AG's has been approved by the U.S. FDA for a rare type of pancreatic cancer.” View full resource at thirdage.com
Most Recently Shared on May 6, 2011 at 7:41 pm By:
Pancreatic Cancer Drug Afinitor Approved By FDA http://bit.ly/mkePjS
Pancreatic cancer: FDA panel recommends use of two drugs for rare form of pancreatic cancer - South Florida Sun-Sentinel.com
sun-sentinel.com — “FDA advisory panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects, increasing the likelihood that the Food and Drug Administration will approve their use against pancreatic neuroendocrine tumors.” View full resource at sun-sentinel.com
Most Recently Shared on April 14, 2011 at 3:21 pm By:
LegalMedsDirect Health Business
FDA panel recommends two drugs for rare form of pancreatic cancer http://dld.bz/W6hT
Pancreatic Cancer Drugs Sutent And Afinitor Recommended By FDA Advisory Committee
medicalnewstoday.com — “Sutent (sunitinib malate) and Afinitor (everolimus) were recommended for approval for the treatment of unresectable pancreatic neuroendocrine tumors, a rare type of pancreatic cancer - by the FD” View full resource at medicalnewstoday.com
Most Recently Shared on April 13, 2011 at 5:05 pm By:
MNT Drug Approvals Health News
Pancreatic Cancer Drugs Sutent And Afinitor Recommended By FDA Advisory Committee http://mnt.to/3TBz #regulatory
Advertisement
MNT Pancreatic Can
@mnt_pancreatic
Pancreatic Cancer Drugs Sutent And Afinitor Recommended By FDA Advisory Committee http://mnt.to/3TBz #pancreaticcancer
1 year ago...